International WM Workshops - WM & MM Poster Session

The following abstracts represent the posters presented at the IWWM-7 conference:

WM Posters:

Gene expression profiling identifies new targets in Waldenström macroglobulinemia to assess and understand clinical aggressiveness

CD 38 expression in Waldenström macroglobulinemia

Isoform-specific Functions for STAT5A and STAT5B in Waldenstrom’s Macroglobulinemia

Identification of immunophenotypically distinct entities within the spectrum of Marginal Zone Lymphoma and Lymphoplasmacytic lymphoma/Waldenstrom Macroglobulinemia

Coexpression of myeloid marker CD13 is a very frequent immunophenotypic feature in Waldenström’s Macroglobulinaemia

Skewed ratios of heavy chains igm-kappa /igm-lambda as measured by hevylite™ characterize remission depth better as immunofixation and free light chain ratios

Prognostic Utility Of Serum Free Light Chain (sFLC) And Their Summated Value sFLC kappa+lambda In Waldenstrom Macroglobulinemia (WM)

Increased serum transforming growth factor-beta (tgf-beta) is related to longer time to first treatment (tft) in MM and improved overall survival (os) in WM

The clinical spectrum of anti-MAG neuropathies at the National Hospital for Neurology

Autologous Stem Cell Transplantation Can Improve the Quality of Response in Rituximab-Treated Lymphoplasmacytic Lymphoma/Waldenström’s Macroglobulinaemia with a Median Time to Best Response of 5 Months

Distinct characteristics of Chinese patients with Waldenström macroglobulinemia: a report with 90 cases from a single representative center

Familiar Waldenstrom´s Macroglobulinemia in Northern part of Sweden

May treatment choice be influenced by comorbid conditions in Waldenstrom’s Macroglobulinemia patients? A revision of a single centre unselected population

Clinical course and factors predicting malignant evolution of IgM MGUS and Smoldering Waldenström’s Macroglobulinemia (sWM)

Role of NK-mediated ADCC in WM patients: evidence supporting a therapeutic strategy with ublituximab, an optimized anti-CD20 monoclonal antibody

Clinical, radiological, and cytogenetic analysis of lymphoplasmacytic lymphoma: a unique disease entity

Autologous stem cell transplantation in Waldenstrom’s macroglobulinemia

Prospective, Multicenter Study of the MTOR inhibitor Everolimus (RAD001) as Primary Therapy in Waldenstrom’s Macroglobulinemia

Prospective Phase II Clinical Trial of Carfilzomib, Rituximab and Dexamethasone (CARD) in Patients with Symptomatic Waldenstrom’s Macroglobulinemia (WM)

MM Posters:

Chromosome aberration in Chinese patients with multiple myeloma: more high-risk MM was found

Secondary monoclonal gammopathy of undetermined significance are frequently associated with superior survival and high depth of response in patients with multiple myeloma

Circulating miRNA-19a and miR-92a in serum as potential markers for different states of multiple myeloma

Importance of novel combination therapy for Multiple Myeloma with a PARP inhibitor

Newport 2012 (IWWM-7)

Click here to display the Newport 2012 Overview page

CHAIR ORGANIZERS:

Kenneth C. Anderson MD
Nikhil Munshi MD
Steven Treon MD Ph.D

ORGANIZING SECRETARIAT:

Christopher Patterson

SCIENTIFIC COMMITTEE:

Ranjana Advani MD
Kenneth C Anderson MD
Stephen Ansell MD PhD
Bruce Cheson MD
Meletios Dimopoulos MD
Jean-Paul Fermand MD
Morie Gertz MD
Irene Ghobrial MD
Stephanie Gregory MD
Robert Kyle MD
Charalampia Kyriakou MD PhD
Ola Landgren MD PhD
Veronique Leblond MD
Mary L McMaster MD
Giampaolo Merlini MD
Pierre Morel MD
Enrica Morra MD
Nikhil Munshi MD
Roger Owen MD
Jesus San Miguel MD PhD
Marvin Stone MD
Steven Treon MD PhD

Click here to download a listing of the IWWM-7 Newport-2012 Invited Faculty

Click here to download the IWWM-7 Newport-2012 Program

The 7th International Workshop on WM (IWWM-7) was made possible through the kind and generous unrestricted grants or gifts from the following sponsors:

Click here to download a listing of the IWWM-7 Newport Sponsors and partners

Choose from the following list of IWWM-7 (Newport-2012) conference sessions:

Pathological Challenges in WM Diagnosis

Genetic Predisposition to WM

Cell Origins and Genetic Basis of WM

Molecular Pathogenesis in WM

Microenvironment and Immune Interactions in WM

Survival in WM: Are We Making Progress? [Debate]

Novel Therapeutic Approaches to WM-Preclinical

Treatment of WM-Primary

Treatment of WM- Salvage

WM & MM Oral & Poster Abstract Presentations

Treatment Debates in WM

Special Topics in the Treatment of WM

Response Assessment in WM

Advances in Multiple Myeloma

WM & MM Poster Session

Reports from the 7th International Workshop on Waldenström’s Macroglobulinemia; August 23-26, 2012; Newport, Rhode Island:

Click here to display the listing of the Newport 2012 Publications

Please select from the following categories of photos from the IWWM-7 Workshop:

Opening Ceremonies

Faculty Presenters

Closing Ceremonies

Newport Photo Gallery

On Sunday, August 26, 2012, a Workshop Review session was held for patients and caregivers. This 2-hour session was recorded onto a DVD, which is available for the nominal price of $10 (includes shipping & handling).

Click here to order the IWWM-7 Newport-2012 Workshop Review DVD

Copyright © 2026 International Waldenström's Macroglobulinemia Workshops. All Rights Reserved.